Mike La Fleur

Michael La Fleur is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as the Chief Executive Officer of Arietis Corporation since May 2008, focusing on the development of innovative small molecule antibiotics to combat drug-resistant bacterial pathogens. Additionally, Michael is the Cofounder and President of Holobiome and a Visiting Scientist at Northeastern University's Antimicrobial Discovery Center, where efforts are directed toward optimizing early-stage drug discovery initiatives. Michael's career includes previous roles as Chief Operating Officer, Senior Manager, and Scientist, emphasizing expertise in drug discovery and development of antimicrobial agents. Educational credentials include a Ph.D. in Molecular Microbiology from Northeastern University and an MBA from the Isenberg School of Management, UMass Amherst.